JP2012532851A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012532851A5 JP2012532851A5 JP2012519021A JP2012519021A JP2012532851A5 JP 2012532851 A5 JP2012532851 A5 JP 2012532851A5 JP 2012519021 A JP2012519021 A JP 2012519021A JP 2012519021 A JP2012519021 A JP 2012519021A JP 2012532851 A5 JP2012532851 A5 JP 2012532851A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- nos
- tlr3
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22454809P | 2009-07-10 | 2009-07-10 | |
| US61/224,548 | 2009-07-10 | ||
| PCT/EP2010/059946 WO2011004028A2 (en) | 2009-07-10 | 2010-07-09 | Tlr3 binding agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012532851A JP2012532851A (ja) | 2012-12-20 |
| JP2012532851A5 true JP2012532851A5 (enExample) | 2013-08-15 |
| JP5800809B2 JP5800809B2 (ja) | 2015-10-28 |
Family
ID=42727505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012519021A Expired - Fee Related JP5800809B2 (ja) | 2009-07-10 | 2010-07-09 | Ｔｌｒ３結合剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9388246B2 (enExample) |
| EP (1) | EP2451844B1 (enExample) |
| JP (1) | JP5800809B2 (enExample) |
| CN (1) | CN102471382A (enExample) |
| AU (1) | AU2010270163B2 (enExample) |
| CA (1) | CA2766747C (enExample) |
| DK (1) | DK2451844T3 (enExample) |
| ES (1) | ES2543095T3 (enExample) |
| RU (1) | RU2562865C2 (enExample) |
| WO (1) | WO2011004028A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2742014A1 (en) | 2008-10-31 | 2010-05-06 | Centocor Ortho Biotech Inc. | Toll-like receptor 3 antagonists |
| US8460659B2 (en) | 2008-10-31 | 2013-06-11 | Janssen Biotech, Inc. | Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases |
| WO2010060186A1 (en) | 2008-11-03 | 2010-06-03 | Alethia Biotherapeutics Inc. | Antibodies that specifically block the biological activity of a tumor antigen |
| EP2451844B1 (en) | 2009-07-10 | 2015-04-22 | Innate Pharma | Tlr3 binding agents |
| EP2663329A2 (en) * | 2011-01-12 | 2013-11-20 | Innate Pharma | Tlr3 binding agents |
| JP6294221B2 (ja) * | 2011-03-31 | 2018-03-14 | アー・デー・ツェー・セラピューティクス・エス・アー | 腎臓関連抗原１に対する抗体およびその抗原結合性フラグメント |
| WO2013078223A1 (en) * | 2011-11-23 | 2013-05-30 | Children's Hospital & Research Center Oakland | Anti-factor h binding protein antibodies and methods of use thereof |
| TR201908872T4 (tr) | 2012-01-09 | 2019-07-22 | Adc Therapeutics Sa | Üçlü negatif meme kanserini tedavi etmek için ajanlar. |
| CN104334581B (zh) * | 2012-05-09 | 2018-02-02 | 伊莱利利公司 | 抗‑c‑Met抗体 |
| CN104379603B (zh) * | 2012-05-31 | 2017-11-07 | 先天制药公司 | Tlr3结合剂 |
| TR201816416T4 (tr) * | 2012-08-21 | 2018-11-21 | Janssen Pharmaceutica Nv | Risperidona yönelik antikorlar ve bunların kullanımı. |
| SG11201604503XA (en) * | 2013-12-03 | 2016-07-28 | Agency Science Tech & Res | Cytotoxic antibody |
| US11111288B2 (en) | 2014-08-28 | 2021-09-07 | Bioatla, Inc. | Conditionally active chimeric antigen receptors for modified t-cells |
| ES3034398T3 (en) | 2014-08-28 | 2025-08-18 | Bioatla Inc | Conditionally active chimeric antigen receptors for modified t-cells |
| EP3455261B1 (en) | 2016-05-13 | 2022-08-03 | BioAtla, Inc. | Anti-ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof |
| CN115427447B (zh) * | 2020-01-17 | 2025-02-18 | 百进生物科技公司 | 抗tlr7药剂和组合物以及制备和使用其的方法 |
| WO2021207152A1 (en) * | 2020-04-06 | 2021-10-14 | Vanderbilt University | Cross-reactive coronavirus antibodies and uses thereof |
| JP2024512305A (ja) * | 2021-03-03 | 2024-03-19 | ザ ユナイテッド ステイツ オブ アメリカ アズ リプリゼンテッド バイ ザ セクレタリー、デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 破骨細胞生成の新規制御因子としてのＬａタンパク質 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5567610A (en) | 1986-09-04 | 1996-10-22 | Bioinvent International Ab | Method of producing human monoclonal antibodies and kit therefor |
| US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US5229275A (en) | 1990-04-26 | 1993-07-20 | Akzo N.V. | In-vitro method for producing antigen-specific human monoclonal antibodies |
| US5660827A (en) | 1992-03-05 | 1997-08-26 | Board Of Regents, The University Of Texas System | Antibodies that bind to endoglin |
| US5491084A (en) | 1993-09-10 | 1996-02-13 | The Trustees Of Columbia University In The City Of New York | Uses of green-fluorescent protein |
| US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
| AR006928A1 (es) | 1996-05-01 | 1999-09-29 | Pioneer Hi Bred Int | Una molecula de adn aislada que codifica una proteina fluorescente verde como marcador rastreable para la transformacion de plantas, un metodo para laproduccion de plantas transgenicas, un vector de expresion, una planta transgenica y celulas de dichas plantas. |
| CN101486759A (zh) | 1997-05-07 | 2009-07-22 | 先灵公司 | 人Toll样受体蛋白、相关试剂和方法 |
| DK0999853T3 (da) | 1997-06-13 | 2003-04-22 | Genentech Inc | Stabiliseret antostofformulering |
| JP4731793B2 (ja) | 2000-12-28 | 2011-07-27 | アルセア テクノロジーズ インコーポレイテッド | 抗体全体またはそのフラグメントの結晶、ならびにこの結晶を作製および使用するための方法 |
| US7595378B2 (en) | 2001-06-13 | 2009-09-29 | Genmab A/S | Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| CA2467242A1 (en) | 2001-11-20 | 2003-05-30 | Seattle Genetics, Inc. | Treatment of immunological disorders using anti-cd30 antibodies |
| CA2480059C (en) | 2002-03-22 | 2015-11-24 | Amrad Operations Pty. Ltd. | Monoclonal antibody against interleukin-13 receptor alpha 1 (il-13r.alpha.1) |
| JP2004016021A (ja) | 2002-06-12 | 2004-01-22 | Japan Science & Technology Corp | 抗体および阻害剤並びにそれを用いた形質転換方法および形質転換キット |
| WO2004032828A2 (en) | 2002-07-31 | 2004-04-22 | Seattle Genetics, Inc. | Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders |
| AR051836A1 (es) * | 2004-11-30 | 2007-02-14 | Centocor Inc | Antagonistas de receptor 3 simil toll metodos y usos |
| JP5199878B2 (ja) | 2005-10-27 | 2013-05-15 | セントカー・インコーポレーテツド | Ｔｏｌｌ様受容体３モジュレーター、方法および用途 |
| DK1957539T3 (da) | 2005-12-08 | 2013-05-06 | Medarex Inc | Humane monoklonale antistoffer til proteintyrosinkinase 7 (ptk7) og deres anvendelse |
| US8354508B2 (en) | 2006-07-21 | 2013-01-15 | Diadexus, Inc. | PRO115 antibody compositions and methods of use |
| WO2008049897A1 (en) | 2006-10-27 | 2008-05-02 | Ablynx N.V. | Intranasal delivery of polypeptides and proteins |
| WO2008140826A1 (en) | 2007-05-15 | 2008-11-20 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for diagnosing and treating cancer |
| US20110076296A1 (en) | 2008-04-25 | 2011-03-31 | Innate Pharma S.A. | TLR3 Agonist Compositions |
| CA2742014A1 (en) | 2008-10-31 | 2010-05-06 | Centocor Ortho Biotech Inc. | Toll-like receptor 3 antagonists |
| US8460659B2 (en) | 2008-10-31 | 2013-06-11 | Janssen Biotech, Inc. | Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases |
| US20130090457A1 (en) | 2008-10-31 | 2013-04-11 | Janssen Biotech, Inc. | Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular Diseases |
| CA2760525A1 (en) | 2009-04-29 | 2010-11-04 | Mark Cunningham | Toll-like receptor 3 antagonists |
| EP2451844B1 (en) | 2009-07-10 | 2015-04-22 | Innate Pharma | Tlr3 binding agents |
| EP2332986B1 (en) | 2009-12-11 | 2013-10-09 | Deutsches Krebsforschungszentrum | Antibody that binds to H-1 parvovirus |
| EP2663329A2 (en) | 2011-01-12 | 2013-11-20 | Innate Pharma | Tlr3 binding agents |
| CN104379603B (zh) | 2012-05-31 | 2017-11-07 | 先天制药公司 | Tlr3结合剂 |
-
2010
- 2010-07-09 EP EP10734092.9A patent/EP2451844B1/en active Active
- 2010-07-09 DK DK10734092.9T patent/DK2451844T3/en active
- 2010-07-09 ES ES10734092.9T patent/ES2543095T3/es active Active
- 2010-07-09 WO PCT/EP2010/059946 patent/WO2011004028A2/en not_active Ceased
- 2010-07-09 RU RU2012103212/10A patent/RU2562865C2/ru active
- 2010-07-09 JP JP2012519021A patent/JP5800809B2/ja not_active Expired - Fee Related
- 2010-07-09 AU AU2010270163A patent/AU2010270163B2/en not_active Ceased
- 2010-07-09 CA CA2766747A patent/CA2766747C/en active Active
- 2010-07-09 CN CN2010800309195A patent/CN102471382A/zh active Pending
-
2011
- 2011-05-05 US US13/102,019 patent/US9388246B2/en not_active Expired - Fee Related
-
2016
- 2016-07-07 US US15/204,851 patent/US20160347853A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012532851A5 (enExample) | ||
| RU2012103212A (ru) | Tlr3 связывающие агенты | |
| HRP20191462T1 (hr) | Antitijela usmjerena protiv her-3 i njihove uporabe | |
| JP2012509881A5 (enExample) | ||
| JP2017519759A5 (enExample) | ||
| JP2013534809A5 (enExample) | ||
| IL290591B1 (en) | Antibody drug conjugates (adc) that bind to 191p4d12 proteins | |
| JP2017535257A5 (enExample) | ||
| JP2015503909A5 (enExample) | ||
| FI3740504T3 (fi) | CD70-yhdistelmähoito | |
| US11851460B2 (en) | PD1 binding agents | |
| RU2010141584A (ru) | Антитело против csf-1r | |
| HRP20151019T1 (hr) | PROTUTIJELA PROTIV c-MET | |
| JP2013529904A5 (enExample) | ||
| RU2013125306A (ru) | Связывающие протеины, специфичные по отношению к инсулин-подобным факторам роста, и их использование | |
| JP2020514277A5 (enExample) | ||
| JP2020522280A5 (enExample) | ||
| RU2010132956A (ru) | Ангиопоэтин-2-специфические связывающие агенты | |
| JP2016538318A5 (enExample) | ||
| JP2025183307A5 (enExample) | ||
| JP2020515277A5 (enExample) | ||
| JP2021512652A5 (enExample) | ||
| JP2017511152A5 (enExample) | ||
| RU2016141285A (ru) | Биспецифические антигенсвязывающие полипептиды | |
| RU2018129180A (ru) | Тромбиновое антитело, антиген-связывающий фрагмент и их фармацевтическое применение |